CS logo
small CS logo
Cancer Institute (WIA)

Chennai, Tamil Nadu, India
Research institution in Chennai, Tamil Nadu
Guindy National Park, Adyar, Chennai, Tamil Nadu 600020

About Cancer Institute (WIA)


The Cancer Institute, also known as the Adyar Cancer Institute, is a non-profit cancer treatment and research centre based in Chennai, Tamil Nadu. The Cancer Institute (WIA) was established in the year 1952 under the leadership of Muthulakshmi Reddy.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Cancer Institute (WIA)


During the past decade, Cancer Institute (WIA) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Cancer Institute (WIA)" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Cancer Institute (WIA)


According to Clinical.Site data, the most researched conditions in "Cancer Institute (WIA)" are "Leukemia" (2 trials), "Breast Neoplasms" (1 trials), "Diffuse Large B-cell Lymphoma" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "Cancer Institute (WIA)" in a lesser frequency.

Clinical Trials Intervention Types at Cancer Institute (WIA)


Most popular intervention types in "Cancer Institute (WIA)" are "Drug" (4 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "asparaginase" (2 trials), "cyclophosphamide" (2 trials), "cytarabine" (2 trials), "daunorubicin hydrochloride" (2 trials) and "mercaptopurine" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Cancer Institute (WIA)


The vast majority of trials in "Cancer Institute (WIA)" are 4 trials for "All" genders.

Clinical Trials Status at Cancer Institute (WIA)


Currently, there are NaN active trials in "Cancer Institute (WIA)". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cancer Institute (WIA), undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Cancer Institute (WIA), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".